On April 3, 2023, HC Wainwright & Co. reiterated coverage of Eyenovia with a Buy recommendation.
https://www.nasdaq.com/articles/hc-wainwright-co.-reiterates-eyenovia-eyen-buy-recommendation
On April 3, 2023, HC Wainwright & Co. reiterated coverage of Eyenovia with a Buy recommendation.
https://www.nasdaq.com/articles/hc-wainwright-co.-reiterates-eyenovia-eyen-buy-recommendation
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.